ORMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
ORAMED PHARMACEUTICALS INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$4.06−0.01 (-0.25%)
Close on Oct 19, 2026
- Market cap
- $172.56M
- P/E (TTM)
- 1.0
- Dividend yield
- 6.16%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
40.3%
17M of 42M shares
Institutional holders
84
29 new, 8 sold out
Net institutional buying
3M
In Q2 2026
Insider trades, 12 months
0 buys · 2 sales
Net sold $941.87K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Nadav Kidron | 3,116,729 | 7.60% | 13D (active) amendment | Feb 11, 2025 |
| BML Investment Partners, L.P. | 2,643,907 | 6.55% | 13G (passive) amendment | Dec 31, 2024 |
| Aquamarine Financial (Cayman) Ltd | 2,512,175 | 6.04% | 13G (passive) amendment | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ORMP | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Mercer Global Advisors Inc /Adv | 3,810,540 | 9.16% | $18.33M | +1,900,000 | 0.02% |
| Aquamarine Financial (Cayman) Ltd | 2,512,175 | 6.04% | $12.08M | +399,863 | 0.67% |
| Gem Investment Advisors, LLC | 1,998,802 | 4.81% | $9.61M | +358,733 | 5.89% |
| BlackRock, Inc. | 1,608,111 | 3.87% | $7.74M | +1,515,919 | 0.00% |
| Murchinson Ltd. | 1,290,294 | 3.10% | $6.21M | −25,000 | 0.86% |
| BML Capital Management, LLC | 866,269 | 2.08% | $4.17M | −2,300,962 | 2.37% |
| Boothbay Fund Management, LLC | 578,638 | 1.39% | $2.78M | −22,078 | 0.04% |
| Geode Capital Management, LLC | 500,690 | 1.20% | $2.41M | +476,408 | 0.00% |
| Goldman Sachs Group Inc | 253,293 | 0.61% | $1.22M | New | 0.00% |
| State Street Corp | 242,100 | 0.58% | $1.16M | New | 0.00% |
| Rathbones Group PLC | 233,018 | 0.56% | $1.12M | −233,018 | 0.00% |
| Vanguard Portfolio Management LLC | 229,882 | 0.55% | $1.11M | New | 0.00% |
| Dimensional Fund Advisors LP | 202,609 | 0.49% | $973.78K | +44,400 | 0.00% |
| Northern Trust Corp | 184,920 | 0.44% | $889.47K | New | 0.00% |
| Renaissance Technologies LLC | 183,800 | 0.44% | $884.08K | +36,100 | 0.00% |
| Wells Fargo & Company/Mn | 166,000 | 0.40% | $798.46K | +8,414 | 0.00% |
| Bank Of America Corp /De/ | 150,694 | 0.36% | $724.84K | +4,542 | 0.00% |
| Strs Ohio | 133,800 | 0.32% | $643.58K | New | 0.00% |
| Jane Street Group, LLC | 113,349 | 0.27% | $545.21K | +60,809 | 0.00% |
| O'Shaughnessy Asset Management, LLC | 102,962 | 0.25% | $495.25K | −13,401 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 84 | 17M | 40.3% | 29 / 21 | 20 / 8 | 7M | 3M |
| Q1 2026 | 64 | 13M | 32.4% | 16 / 19 | 16 / 8 | 3M | 1M |
| Q4 2025 | 57 | 13M | 32.1% | 15 / 14 | 10 / 5 | 5M | 1M |
| Q3 2025 | 47 | 9M | 22.1% | 5 / 9 | 10 / 5 | 2M | 0M |
| Q2 2025 | 47 | 7M | 17.5% | 4 / 8 | 15 / 9 | 0M | 1M |
| Q1 2025 | 52 | 8M | 18.7% | 4 / 15 | 18 / 8 | 1M | 0M |
| Q4 2024 | 56 | 8M | 18.4% | 9 / 14 | 17 / 8 | 1M | 0M |
| Q3 2024 | 55 | 7M | 16.7% | 8 / 14 | 14 / 11 | 1M | 0M |
| Q2 2024 | 59 | 6M | 14.3% | 10 / 12 | 15 / 2 | 1M | 1M |
| Q1 2024 | 51 | 5M | 12.9% | 8 / 14 | 12 / 13 | 1M | 1M |
| Q4 2023 | 56 | 5M | 12.6% | 9 / 18 | 10 / 9 | 3M | 0M |
| Q3 2023 | 56 | 2M | 5.5% | 14 / 12 | 14 / 6 | 1M | 1M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of ORMP | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Russell 2000 ETF | 634,585 | 1.53% | $3.05M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 378,478 | 0.91% | $1.54M | 0.00% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF | 318,598 | 0.77% | $1.53M | 0.01% | Jun 30, 2026 |
| iShares Micro-Cap ETF | 114,970 | 0.28% | $553.01K | 0.04% | Jun 30, 2026 |
| Schwab Small-Cap Index Fund | 83,634 | 0.20% | $340.39K | 0.00% | Jul 31, 2026 |
| Master Small Cap Index Series | 63,616 | 0.15% | $305.99K | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Value Index Fund | 48,747 | 0.12% | $234.47K | 0.01% | Jun 30, 2026 |
| Nuveen Small Cap Blend Index Fund | 46,404 | 0.11% | $188.86K | 0.00% | Jul 31, 2026 |
| Dimensional U.S. Small Cap ETF | 40,483 | 0.10% | $164.77K | 0.00% | Jul 31, 2026 |
| Dimensional U.S. Core Equity 2 ETF | 36,536 | 0.09% | $148.70K | 0.00% | Jul 31, 2026 |
| EQ/2000 Managed Volatility Portfolio | 33,545 | 0.08% | $161.35K | 0.00% | Jun 30, 2026 |
| Nationwide Bailard Small Cap Value Fund | 32,478 | 0.08% | $132.19K | 0.10% | Jul 31, 2026 |
| Avantis U.S. Small Cap Equity ETF | 28,155 | 0.07% | $111.78K | 0.00% | May 31, 2026 |
| LVIP State Street Small-Cap Index Fund | 25,700 | 0.06% | $123.62K | 0.01% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 24,282 | 0.06% | $96.40K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Miriam Kidron | Chief Scientific Officer, Director | 1,341,263 | 3.22% | Sep 25, 2026 |
| Nadav Kidron | President and CEO, Director | 3,897,740 | 9.37% | Sep 25, 2026 |
| Joshua Hexter | COO & CBO | 1,358,130 | 3.26% | Sep 25, 2026 |
| Avraham Gabay | Chief Financial Officer | 881,076 | 2.12% | Sep 25, 2026 |
| Yehuda Reznick | Director | 98,930 | 0.24% | Jan 5, 2026 |
| Arie Mayer | Director | 168,009 | 0.40% | Jan 5, 2026 |
| Benjamin Shapiro | Director | 2,023,220 | 4.86% | Jan 5, 2026 |
| Daniel Aghion | Director | 107,191 | 0.26% | Jan 2, 2026 |
| Leonard Sank | Director | 273,420 | 0.66% | Jun 9, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Nadav Kidron President and CEO, Director | Sep 24, 2026 | Award | +349,497 | – | – | 3,771,740 |
| Nadav Kidron President and CEO, Director | Sep 24, 2026 | Award | +368,765 | – | – | 4,140,505 |
| Avraham Gabay Chief Financial Officer | Sep 24, 2026 | Award | +209,291 | – | – | 881,076 |
| Miriam Kidron Chief Scientific Officer, Director | Sep 24, 2026 | Award | +208,125 | – | – | 1,341,263 |
| Miriam Kidron Chief Scientific Officer, Director | Sep 24, 2026 | Award | +209,291 | – | – | 1,550,554 |
| Joshua Hexter COO & CBO | Sep 24, 2026 | Award | +209,291 | – | – | 1,358,130 |
| Joshua Hexter COO & CBO | Sep 24, 2026 | Award | +75,455 | – | – | 1,148,839 |
| Joshua Hexter COO & CBO | Jul 2, 2026 | Option exercise | +50,000 | $3.69 | $184.50K | 1,073,384 |
| Avraham Gabay Chief Financial Officer | Jul 1, 2026 | Sale(10b5-1 plan) | −73,360 | $4.51 | $330.85K | 671,785 |
| Joshua Hexter COO & CBO | Jul 1, 2026 | Sale(10b5-1 plan) | −137,000 | $4.46 | $611.02K | 1,023,384 |
| Miriam Kidron Chief Scientific Officer, Director | Mar 30, 2026 | Tax withholding | −435,084 | $3.31 | $1.44M | 1,133,138 |
| Nadav Kidron President and CEO, Director | Mar 30, 2026 | Tax withholding | −44,818 | $3.31 | $148.35K | 3,422,243 |
| Joshua Hexter COO & CBO | Mar 17, 2026 | Award | +95,889 | – | – | 1,160,384 |
| Nadav Kidron President and CEO, Director | Mar 17, 2026 | Award | +167,005 | – | – | 3,422,243 |
| Miriam Kidron Chief Scientific Officer, Director | Mar 17, 2026 | Award | +119,558 | – | – | 1,568,222 |
| Avraham Gabay Chief Financial Officer | Mar 17, 2026 | Award | +95,889 | – | – | 745,145 |
| Nadav Kidron President and CEO, Director | Mar 12, 2026 | Gift | −100,000 | – | – | 3,255,238 |
| Nadav Kidron President and CEO, Director | Jan 22, 2026 | Option exercise | +109,000 | – | – | 3,355,238 |
| Avraham Gabay Chief Financial Officer | Jan 22, 2026 | Option exercise | +19,000 | – | – | 649,256 |
| Miriam Kidron Chief Scientific Officer, Director | Jan 22, 2026 | Option exercise | +19,000 | – | – | 1,448,664 |
| Joshua Hexter COO & CBO | Jan 22, 2026 | Option exercise | +19,000 | – | – | 1,064,495 |
| Miriam Kidron Chief Scientific Officer, Director | Jan 14, 2026 | Gift | −86,166 | – | – | 1,343,498 |
| Benjamin Shapiro Director | Dec 31, 2025 | Award | +3,500 | – | – | 123,220 |
| Benjamin Shapiro Director | Dec 31, 2025 | Award | +30,000 | – | – | 119,720 |
| Nadav Kidron President and CEO, Director | Dec 31, 2025 | Award | +232,640 | – | – | 2,919,238 |
| Nadav Kidron President and CEO, Director | Dec 31, 2025 | Award | +327,000 | – | – | 3,246,238 |
| Yehuda Reznick Director | Dec 31, 2025 | Award | +30,000 | – | – | 98,930 |
| Yehuda Reznick Director | Dec 31, 2025 | Award | +6,250 | – | – | 105,180 |
| Joshua Hexter COO & CBO | Dec 31, 2025 | Award | +115,000 | – | – | 1,045,495 |
| Joshua Hexter COO & CBO | Dec 31, 2025 | Award | +97,328 | – | – | 930,495 |
| Arie Mayer Director | Dec 31, 2025 | Award | +4,900 | – | – | 168,009 |
| Arie Mayer Director | Dec 31, 2025 | Award | +30,000 | – | – | 163,109 |
| Miriam Kidron Chief Scientific Officer, Director | Dec 31, 2025 | Award | +115,000 | – | – | 1,429,664 |
| Miriam Kidron Chief Scientific Officer, Director | Dec 31, 2025 | Award | +121,331 | – | – | 1,314,664 |
| Avraham Gabay Chief Financial Officer | Dec 31, 2025 | Award | +81,216 | – | – | 515,256 |
| Avraham Gabay Chief Financial Officer | Dec 31, 2025 | Award | +115,000 | – | – | 630,256 |
| Daniel Aghion Director | Dec 31, 2025 | Award | +30,000 | – | – | 107,191 |
| Daniel Aghion Director | Dec 31, 2025 | Award | +6,250 | – | – | 113,441 |
| Daniel Aghion Director | Jun 5, 2025 | Award | +30,000 | – | – | 68,820 |
| Daniel Aghion Director | Jun 5, 2025 | Award | +8,371 | – | – | 77,191 |
| Benjamin Shapiro Director | Jun 5, 2025 | Award | +30,000 | – | – | 85,070 |
| Benjamin Shapiro Director | Jun 5, 2025 | Award | +4,650 | – | – | 89,720 |
| Arie Mayer Director | Jun 5, 2025 | Award | +6,975 | – | – | 133,109 |
| Arie Mayer Director | Jun 5, 2025 | Award | +30,000 | – | – | 126,134 |
| Yehuda Reznick Director | Jun 5, 2025 | Award | +30,000 | – | – | 60,560 |
| Yehuda Reznick Director | Jun 5, 2025 | Award | +8,370 | – | – | 68,930 |
| Leonard Sank Director | Jun 5, 2025 | Award | +6,510 | – | – | 134,531 |
| Leonard Sank Director | Jun 5, 2025 | Award | +30,000 | – | – | 128,021 |
| Joshua Hexter COO & CBO | Feb 11, 2025 | Award | +33,334 | – | – | 833,167 |
| Joshua Hexter COO & CBO | Feb 11, 2025 | Award | +48,500 | – | – | 799,833 |
| Joshua Hexter COO & CBO | Feb 11, 2025 | Award | +45,000 | – | – | 751,333 |
| Miriam Kidron Chief Scientific Officer, Director | Feb 11, 2025 | Award | +74,000 | – | – | 1,074,666 |
| Miriam Kidron Chief Scientific Officer, Director | Feb 11, 2025 | Award | +52,000 | – | – | 1,126,666 |
| Miriam Kidron Chief Scientific Officer, Director | Feb 11, 2025 | Award | +66,667 | – | – | 1,193,333 |
| Nadav Kidron President and CEO, Director | Feb 11, 2025 | Award | +186,000 | – | – | 2,586,598 |
| Nadav Kidron President and CEO, Director | Feb 11, 2025 | Award | +141,000 | – | – | 2,400,598 |
| Nadav Kidron President and CEO, Director | Feb 11, 2025 | Award | +100,000 | – | – | 2,686,598 |
| Avraham Gabay Chief Financial Officer | Feb 11, 2025 | Award | +42,000 | – | – | 434,040 |
| Avraham Gabay Chief Financial Officer | Feb 11, 2025 | Award | +34,000 | – | – | 392,040 |
| Miriam Kidron Chief Scientific Officer, Director | Jan 2, 2025 | Award | +207,000 | – | – | 1,000,666 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Hexter Joshua Officer | Oct 1, 2026 | 30,000 | $140.10K | Oct 1, 2026 | Shares issued upon vesting of RSUs |
| Gabay Avi Officer | Oct 1, 2026 | 20,000 | $93.40K | Oct 1, 2026 | Shares issued upon vesting of RSUs |
| Joshua Hexter Officer | Jul 1, 2026 | 137,000 | $658.97K | Jul 1, 2026 | Shares issued upon vesting of RSUs |
| Avraham Gabay Officer | Jul 1, 2026 | 93,360 | $449.06K | Jul 1, 2026 | Shares issued upon vesting of RSUs |